Canada markets closed

Sunshine Biopharma, Inc. (SBFM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8000-0.0290 (-3.50%)
At close: 03:59PM EDT
0.7890 -0.01 (-1.38%)
After hours: 07:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.8290
Open0.8054
Bid0.7931 x 900
Ask0.8112 x 1000
Day's Range0.7862 - 0.8299
52 Week Range0.7010 - 9.8700
Volume78,465
Avg. Volume1,023,362
Market Cap15.108M
Beta (5Y Monthly)-1.33
PE Ratio (TTM)N/A
EPS (TTM)-2.2140
Earnings DateAug 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Simply Wall St.

    We're Hopeful That Sunshine Biopharma (NASDAQ:SBFM) Will Use Its Cash Wisely

    We can readily understand why investors are attracted to unprofitable companies. For example, although...

  • GlobeNewswire

    Sunshine Biopharma Files Its Second Quarter Report With the SEC

    Company Reports Significant Increase in Cash on Hand as a Result of Recent FinancingsMONTREAL, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has filed its 2022 second quarter report with the Securities and Exchange Commission. The Report shows that the Company had Cash & Cash Equivalents of $41,727,775 as of June 3

  • GlobeNewswire

    Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona

    MONTREAL, July 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it has agreed to provide additional resources to the University of Arizona R. Ken Coit College of Pharmacy for the purposes of accelerating the development of novel PLpro inhibitors currently underway. The development of the Co